Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
INHERET, Inc. logo — INHERET reduces the barriers physicians face in identifying...

INHERET, Inc.

INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease

Founded 2018 United States Ann Arbor, United States 3 employees Seed Total: $3.18M Health Care, IT +1

General Information

Company Name INHERET, Inc.
Founded Year 2018
Location United States Ann Arbor, United States
Employees 3
Industries Health Care, IT, Information Technology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with INHERET, Inc.. To contact INHERET, Inc., visit inheret.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does INHERET, Inc. compare?

A PDF of INHERET, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting INHERET, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About INHERET, Inc.

INHERET, Inc. is a Health Care and Information Technology startup based in the United States. Founded in 2018, the company aims to reduce the barriers physicians face in identifying patients at increased risk for hereditary diseases. With the slogan "INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease," the company provides Comprehensive Risk Assessment with a Personalized Approach, evaluating family health histories, and offering personalized risk reduction strategies for individuals. Recently, on 02 May 2022, the company secured a $580.00K Seed Round investment from the Accelerate Blue Fund. With its mission to improve hereditary disease identification and prevention, INHERET, Inc. is poised to make a significant impact in the healthcare industry with its innovative approach.

Business keywords: personalized medicine, hereditary disease, risk assessment, physician support, patient risk identification, preventive healthcare, family health history, cancer risk assessment, early detection, healthcare analytics, clinical decision support, patient education, genetic risk evaluation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $580.00K 1
Accelerate Blue Fund
Accelerate Blue Fund
02 May 2022
Grant $2.60M 1
National Cancer Institute
18 Sep 2020

INHERET, Inc. Alternatives & Competitors

View All Alternatives
INHERET, Inc. vs
Mesh Bio
Mesh Bio Singapore

Multidimensional Health Intelligence Platform for digital twin and computational biology enabled car...

Series A
27 employees
AI, Analytics
INHERET, Inc. vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care
INHERET, Inc. vs
CLINICOM
CLINICOM United States

World’s First Comprehensive DSM based Clinical Decision support platform and Augmented Intelligence...

Seed
34 employees
Health Care, Health and Wellness
View all alternatives

FAQ About INHERET, Inc.

INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease
INHERET, Inc. was founded in 2018.
INHERET, Inc. is headquartered in Ann Arbor, United States.
INHERET, Inc. operates in Health Care, IT and Information Technology. Its work centres on personalized medicine, hereditary disease, risk assessment and physician support.
INHERET, Inc. has approximately 3 employees.
INHERET, Inc. has completed 2 funding rounds, raising a total of $3.18M. The latest funding stage is Seed.
Top alternatives and competitors to INHERET, Inc. include Mesh Bio, ACT Genomics, CLINICOM, TIIM Healthcare, Vital Beats. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
INHERET, Inc. and Mesh Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for INHERET, Inc., https://bouncewatch.com/company/inheret-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout